Is a complete VERA research report available?

No complete published report is available for Vera Therapeutics, Inc. (VERA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · USD

$32.5

-0.81 (-2.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first VERA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.3B
Net income (ttm)	-369M
EPS (ttm)	-$5.57
Shares out	71.8M
Volume	1,469,225
Beta	0.92
Price target	$81.8	+151.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -369M
EPS (ttm): -$5.57
Market cap: 2.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All VERA indicators

Market & fundamental data

Available fields

191

Groups with data

Currency

USD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001831828
Company name	Vera Therapeutics, Inc.
Country	United States
Country code	US
Cusip	92337R101
Employees	339
Employees Change	90%
Employees Change Percent	36.14
Enterprise value	$1.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-05-14
Isin	US92337R1014
Last refreshed	2026-07-30
Market cap	$2.3B
Market cap category	Mid-Cap
Price	$32.51
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	VERA
Website	https://veratx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.81%
EV Sales Forward	25.55x
FCF yield	-12.58%
P/B ratio	4.67x
PS Forward	32.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-369M
Net Income Growth Years	0%
Profit Per Employee	$-1.1M
ROA	-38.9
Roa5y	-35.79
ROCE	-66.5
ROE	-71.32
Roe5y	-75.81
ROIC	-41.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	55.82%
Cagr3y	23.64%
Cagr5y	12.68%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$621.7M
Cash	$596.8M
Current Assets	$615.8M
Current Liabilities	$45.1M
Debt	$76.9M
Debt Equity	$0.15
Equity	$499.7M
Interest Coverage	-50.7
Liabilities	$122M
Long Term Assets	$5.9M
Long Term Liabilities	$76.9M
Net Cash	$519.9M
Net Cash By Market Cap	$22.27
Net Cash Growth	-2.9%
Net Debt Equity	$-1.04
Tangible Book Value	$499.7M
Tangible Book Value Per Share	$6.97
WACC	9.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.64
Net Working Capital	$-26.1M
Quick ratio	13.3
Working Capital	$570.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.13%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	55.77%
200-day SMA	38.91
3Y total return	89.01%
50-day SMA	36.81
50-day SMA vs 200-day SMA	50under200
5Y total return	81.62%
All Time High	56.05
All Time High Change	-42%
All Time High Date	2025-12-24
All Time Low	5.2
All Time Low Change	525.19%
All Time Low Date	2023-01-06
ATR	2.17
Beta	0.92
Beta1y	1
Beta2y	1.22
Ch YTD	-35.8
High	33.52
High52	56.05
High52 Date	2025-12-24
High52ch	-42%
Low	32.04
Low52	19.07
Low52 Date	2025-08-07
Low52ch	70.51%
Ma50ch	-11.69%
Premarket Change Percent	-0.32
Premarket Price	$33.21
Premarket Volume	4,121
Price vs 200-day SMA	-16.45%
RSI	30.23
RSI Monthly	49.5
RSI Weekly	42.7
Sharpe ratio	0.98x
Sortino ratio	1.76
Total Return	-13.13%
Tr YTD	-35.8
Tr1m	-23.43%
Tr1w	-9.83%
Tr3m	-12.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	12
Analyst Price Target Top	$85.18
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.69
Operating Income	$-383.4M
Price target	$81.79
Price Target Change	$152
Price Target Change Top	$162

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	51,951,458%
Float Percent	72.37%
Net Borrowing	23,338,000
Shares Insiders	1%
Shares Institutions	83.57%
Shares Out	71,782,904
Shares Qo Q	8.92%
Shares Yo Y	13.13%
Short Float	29.03%
Short Ratio	5.77
Short Shares	21.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-337.1M
Adjusted OCF	-336,588,000
Average Volume	2,196,834.8x
Bv Per Share	6.97
CAPEX	$-466,000
Ch1m	-23.43
Ch1w	-9.83
Ch1y	55.77
Ch3m	-12.4
Ch3y	89.01
Ch5y	81.62
Ch6m	-27.93
Change	-2.43%
Change From Open	-1.45
Close	33.32
Days Gap	-0.99
Depreciation Amortization	523,000
Dollar Volume	47,764,504.8
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$-383.4M
EBITDA	$-382.9M
EPS	$-5.57
F Score	1
FCF	$-293.7M
FCF EV Yield	-16.18x
FCF Per Share	$-4.09
Financing CF	311,306,000
Fiscal Year End	December
Founded	2,016
Income Tax	$1,000
Investing CF	41,153,000
Ipr	195.5
Iprfo	184.9
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	40.61
Ma150ch	-19.94%
Ma20	39.08
Ma20ch	-16.81%
Net CF	59,261,000
Next Earnings Date	2026-08-11
Open	32.99
Optionable	Yes
Position In Range	31.76
Post Close	32.51
Postmarket Change Percent	-1.57
Postmarket Price	$32
Ppne	2,751,000
Pre Close	33.32
Price Date	2026-07-29
Ptbv Ratio	4.67
Relative Volume	0.67x
Share Based Comp	43,390,000
Tr6m	-27.93%
Us State	California
Volume	1,469,225

Vera Therapeutics, Inc. (VERA)

Coverage state: Market snapshot only — no published research

Generate the first VERA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · VERA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VERA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on VERA

Frequently asked questions